gip and glp-1 agonist Why does GLP‐1 combined with and/or GCG agonist have greater weight loss effect than GLP‐1 agonist alone in obese adults without type 2 diabetes? - Jiang - 2025 Targeting GLP-1, GIP & GCG

Data from designated brain regions from the cFOS 3D brain imaging study were analysed using one-way ANOVA with Dunnets post hoc multiple-comparison test relative to the vehicle, using a negative binomial generalized linear model to control for Gaussian distribution

In case you missed it, here is a link to part 1 of this series

Additionally, these agents have been shown to slow the progression of diabetic kidney disease, offering a dual benefit for patients at risk

Clinical outcomes of tirzepatide or GLP-1 receptor agonists in individuals with type 2 diabetes

Call 911 immediately if vision symptoms occur with BE-FAST stroke symptoms, fainting, confusion, seizure, or sudden severe headache

GLP1 and cancer: friend or foe